Aliro announced today that AliroNet® has been named a Gold winner in the 21st Annual 2025 Globee Awards for Cybersecurity. This prestigious awards program honors excellence and innovation in ...
PortX, a leading financial infrastructure and integration technology company that provides open access to the core and drives innovation for financial institutions with its ...
The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...
Positive results from the pivotal ADEPT phase 2/3 study evaluating the investigational use of Dupixent (dupilumab) in adults with moderate-to-severe bullous pemphigoid (BP) were shared in a ...
Dupixent, a blockbuster anti-IL4-alpha antagonist, was cleared for the lung condition after Phase III trials demonstrated a 30% to 34% drop in the rate of exacerbations versus placebo. In April 2024, ...
They also had significantly higher plasma levels of IL4, CCL20, CSF2 and MMP12, with 11 % of the exposed workers showing elevated levels of shrimp and crab specific IgE. Furthermore, exposed workers ...
Armis previously achieved FedRAMP Moderate and DISA IL4 authorizations in 2023. “With the explosion of connected assets, Federal entities must ensure their entire attack surface is defended and ...
A defining feature of successful vaccination is the ability to induce long-lived antigen-specific memory cells. T follicular helper (Tfh) cells specialize in providing help to B cells in mounting ...
Background & Aims: Eosinophils are the main inflammatory effector cells that damage gastrointestinal tissue in eosinophilic gastrointestinal diseases (EGIDs). Activation of the OX40 pathway aggravates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback